Intestinal neoplasia in the ApcMin mouse: independence from the microbial and natural killer (beige locus) status.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Cancer Research

• Publication date

  1997-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 9041176
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Action of Min and Mom1 on neoplasia in ectopic intestinal grafts.

  1996cited by this paper
• Frequency and histological appearance of adenomas in multiple intestinal neoplasia mice are unaffected by severe combined immunodeficiency (scid) mutation

  1996cited by this paper
• Chemoprevention of spontaneous intestinal adenomas in the Apc Min mouse model by the nonsteroidal anti-inflammatory drug piroxicam.

  1996cited by this paper
• A Model of Host-Microbial Interactions in an Open Mammalian Ecosystem

  1996cited by this paper
• N-ethyl-N-nitrosourea treatment of multiple intestinal neoplasia (Min) mice: age-related effects on the formation of intestinal adenomas, cystic crypts, and epidermoid cysts.

  1995cited by this paper
• The secretory phospholipase A2 gene is a candidate for the Mom1 locus, a major modifier of ApcMin-induced intestinal neoplasia.

  1995cited by this paper
• Bactericidal properties of murine intestinal phospholipase A2.

  1995cited by this paper
• Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse.

  1993cited by this paper
• Transgenic mouse models that explore the multistep hypothesis of intestinal neoplasia

  1993cited by this paper
• MHC class I expression on tumor targets inhibits natural killer cell-mediated cytotoxicity without interfering with target recognition.

  1993cited by this paper
• An in vitro adherence assay reveals that Helicobacter pylori exhibits cell lineage-specific tropism in the human gastric epithelium.

  1993cited by this paper
• Corrections and Clarifications: Multiple Intestinal Neoplasia Caused By a Mutation in the Murine Homolog of the APC Gene

  1992cited by this paper
• Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation.

  1991cited by this paper
• A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse.

  1990cited by this paper
• The beige mutation in the mouse. I. A stem cell predetermined impairment in natural killer cell function.

  1979cited by this paper
• Susceptibility to spontaneous pneumonitis in an inbred strain of beige and satin mice.

  1972cited by this paper
• Tumor induction in germfree rats with methylazoxymethanol (MAM) and synthetic MAM acetate.

  1967cited by this paper

• Drug interactions between cephalosporins and 5-FU-based chemotherapy in the treatment of patients with gastrointestinal cancer - an exploratory cohort analysis

  2025cites this paper
• Gut microbiota links to histological damage in chronic HBV infection patients and aggravates fibrosis via fecal microbiota transplantation in mice

  2025cites this paper
• From the Colon to the Liver: How Gut Microbiota May Influence Colorectal Cancer Metastatic Potential

  2024cites this paper
• A guide to germ‐free and gnotobiotic mouse technology to study health and disease

  2024cites this paper
• Development of a new flippase-dependent mouse model for red fluorescence-based isolation of KrasG12D oncogene-expressing tumor cells

  2024cites this paper
• Probiotics intervention in colorectal cancer: From traditional approaches to novel strategies

  2023cites this paper
• Murine models of colorectal cancer: the azoxymethane (AOM)/dextran sulfate sodium (DSS) model of colitis-associated cancer

  2023cites this paper
• Influence of neo-adjuvant radiotherapy on the intestinal microbiota of rectal cancer patients

  2023cites this paper
• Microbes Contribute to Chemopreventive Efficacy, Intestinal Tumorigenesis and the Metabolome.

  2022cites this paper
• Implication of gut microbes and its metabolites in colorectal cancer

  2022cites this paper
• Decreased NHE3 expression in colon cancer is associated with DNA damage, increased inflammation and tumor growth

  2022cites this paper
• Inflammatory bowel disease and carcinogenesis

  2022cites this paper
• Colorectal cancer screening in IBD - can characterization of GI microbiome signatures enhance neoplasia detection?

  2022cites this paper
• Cancer: A sui generis threat and its global impact

  2022cites this paper
• Tumor models to assess immune response and tumor-microbiome interactions in colorectal cancer.

  2021cites this paper
• CXCL13 promotes intestinal tumorigenesis through the activation of epithelial AKT signaling.

  2021cites this paper
• The Microbiome and Its Implications in Cancer Immunotherapy

  2021cites this paper
• Faecal microbial biomarkers in early diagnosis of colorectal cancer

  2021cites this paper
• Microbial Biomarkers for Colorectal Cancer Identified with Random Forest Model

  2020cites this paper
• Diet and Environment in Colorectal Cancer Development, Roles of

  2020cites this paper
• Microbiota, mucosal immunity, and Colon cancer

  2020cites this paper
• Diet—microbiome interaction in colorectal cancer: a potentially discriminatory role for Fusobacterium nucleatum

  2020cites this paper
• The Microbiota and Gut-Related Disorders: Insights from Animal Models

  2020cites this paper
• Integrative Analysis of Fecal Metagenomics and Metabolomics in Colorectal Cancer

  2020cites this paper
• Role of Microbiome in Modulating Immune Responses in Cancer

  2019cites this paper
• Infectious Organisms Associated With Colorectal Cancer

  2019cites this paper
• Clinical applications of gut microbiota in cancer biology.

  2019cites this paper
• Title Antitumor activity of the MEK inhibitor trametinib on intestinal polyp formation in Apc [ Δ 716 ] mice involves stromal

  2019cites this paper
• The Presence of Gut Microbial Genes Encoding Bacterial Genotoxins or Pro-Inflammatory Factors in Stool Samples from Individuals with Colorectal Neoplasia

  2019cites this paper
• Host–MicroRNA–Microbiota Interactions in Colorectal Cancer

  2019cites this paper
• Analysis of Intestinal Mucosal Microbiome Changes before and after Chemoradiation in Locally Advanced Rectal Cancer Patients

  2019cites this paper
• Innate Sensing through Mesenchymal TLR4/MyD88 Signals Promotes Spontaneous Intestinal Tumorigenesis

  2019cites this paper
• The critical role of calcineurin/NFAT (C/N) pathways and effective antitumor prospect for colorectal cancers

  2019cites this paper
• Hyaluronic Acid Binding to TLR4 Promotes Proliferation and Blocks Apoptosis in Colon Cancer

  2019cites this paper
• Mikrobielle Einflüsse in der Tumorentwicklung und Tumortherapie

  2019cites this paper
• An In Vivo Mouse Model of Pelvic Recurrence of Human Colorectal Cancer

  2019cites this paper
• Relationship Between Microbiome and Colorectal Cancer

  2019cites this paper
• Rôle de l'autophagie dans la réponse de l'hôte suite à l'infection par des Escherichia Coli producteurs de colibactine isolés de patients atteints d'un cancer colorectal

  2018cites this paper
• The Effect of Microbiota on Colon Carcinogenesis

  2018cites this paper
• Grow With the Challenge – Microbial Effects on Epithelial Proliferation, Carcinogenesis, and Cancer Therapy

  2018cites this paper
• Comparison of Microbiota in Patients Treated by Surgery or Chemotherapy by 16S rRNA Sequencing Reveals Potential Biomarkers for Colorectal Cancer Therapy

  2018cites this paper
• The controversial role of Enterococcus faecalis in colorectal cancer

  2018cites this paper
• Colon Cancer Prevention

  2018cites this paper
• Mast cells promote small bowel cancer in a tumor stage-specific and cytokine-dependent manner

  2018cites this paper
• Access

  2018cites this paper
• The association of diet, gut microbiota and colorectal cancer: what we eat may imply what we get

  2018cites this paper
• Microbiota control acute arterial inflammation and neointimal hyperplasia development after arterial injury

  2018cites this paper
• Detecting Microbiome in Human Colorectal Cancers from High Throughput Sequencing Data

  2018cites this paper
• The microbiome, its molecular mechanisms and its potential as a therapeutic strategy against colorectal carcinogenesis (Review)

  2018cites this paper
• Locoregional Effects of Microbiota in a Preclinical Model of Colon Carcinogenesis.

  2017cites this paper
• Propriétés antinéoplasiques des composantes membranaires des bactéries probiotiques et des métabolites secondaires des petits fruits

  2017cites this paper
• Inflammatory Molecule, PSGL-1, Deficiency Activates Macrophages to Promote Colorectal Cancer Growth through NFκB Signaling

  2017influential citation
• An investigation of volatile organic compounds as biomarkers for gastrointestinal neoplasia

  2017cites this paper
• Le microbiote intestinal : quels impacts sur la carcinogenèse et le traitement du cancer colorectal ?

  2017cites this paper
• Interaction between Host MicroRNAs and the Gut Microbiota in Colorectal Cancer

  2017cites this paper
• The Human Microbiome and Cancer

  2017cites this paper
• [Gut microbiota: What impact on colorectal carcinogenesis and treatment?]

  2017cites this paper
• How the microbiome is shaping our understanding of cancer biology and its treatment

  2017cites this paper
• Microbiome‐driven carcinogenesis in colorectal cancer: Models and mechanisms

  2017cites this paper
• Gavage of Fecal Samples From Patients With Colorectal Cancer Promotes Intestinal Carcinogenesis in Germ-Free and Conventional Mice.

  2017cites this paper
• Epithelial calcineurin controls microbiota-dependent intestinal tumor development

  2016cites this paper
• Effect of Vitamin D Deficiency on Autophagy in the Intestine via MicroRNA Regulation

  2016cites this paper
• The Myeloid Immune Signature of Enterotoxigenic Bacteroides Fragilis-Induced Murine Colon Tumorigenesis

  2016cites this paper
• Gut Microbiota, Inflammation, and Colorectal Cancer.

  2016cites this paper
• The Gut Epithelial Receptor LRRC19 Promotes the Recruitment of Immune Cells and Gut Inflammation

  2016cites this paper
• In vitro selection of fluorogenic RNA-cleaving DNAzymes for colorectal cancer detection

  2016cites this paper
• The interplay between inflammation and microbial activities in colorectal cancer

  2016cites this paper
• Cancer preventive effect of a specific probiotic fermented milk components and cell walls extracted from a biomass containing L. acidophilus CL1285, L. casei LBC80R, and L. rhamnosus CLR2 on male F344 rats treated with 1,2-dimethylhydrazine

  2016cites this paper
• The interplay between the microbiome and the adaptive immune response in cancer development

  2016cites this paper
• Endogenous conversion of ω‐6 to ω‐3 polyunsaturated fatty acids in fat‐1 mice attenuated intestinal polyposis by either inhibiting COX‐2/β‐catenin signaling or activating 15‐PGDH/IL‐18

  2016cites this paper
• Know your neighbor: Microbiota and host epithelial cells interact locally to control intestinal function and physiology.

  2016cites this paper
• Functional analysis of the relationship between intestinal microbiota and the expression of hepatic genes and pathways during the course of liver regeneration.

  2016cites this paper
• Microbiota and bile acid profiles in retinoic acid-primed mice that exhibit accelerated liver regeneration

  2015cites this paper
• Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer

  2015cites this paper
• Microbial influences on hormesis, oncogenesis, and therapy: A review of the literature.

  2015cites this paper
• Effects of Lactobacillus salivarius Ren on cancer prevention and intestinal microbiota in 1, 2-dimethylhydrazine-induced rat model

  2015cites this paper
• Chronic inflammation and the development of malignancy in the GI tract.

  2015cites this paper
• Differential susceptibility to colorectal cancer due to naturally occurring gut microbiota

  2015cites this paper
• Fusobacterium and Escherichia: models of colorectal cancer driven by microbiota and the utility of microbiota in colorectal cancer screening

  2015cites this paper
• Intestinales Mikrobiom und chronisch-entzündliche Darmerkrankungen: Feindschaft oder Freundschaft?

  2015cites this paper
• Altered Interactions between the Gut Microbiome and Colonic Mucosa Precede Polyposis in APCMin/+ Mice

  2015cites this paper
• T-cell Expression of IL10 Is Essential for Tumor Immune Surveillance in the Small Intestine

  2015cites this paper
• Antitumor activity of the MEK inhibitor trametinib on intestinal polyp formation in ApcΔ716 mice involves stromal COX-2

  2015cites this paper
• Small-molecule inhibitors prevent the genotoxic and protumoural effects induced by colibactin-producing bacteria

  2015cites this paper
• Colorectal Adenocarcinoma and Inflammatory Bowel Disease: An Update and Review

  2015cites this paper
• New insights from animal models of colon cancer: inflammation control as a new facet on the tumor suppressor APC gem

  2015cites this paper
• Intestinal Inflammation and Cancer of the Gastrointestinal Tract

  2015cites this paper
• Group 3 innate lymphoid cells: regulating host-commensal bacteria interactions in inflammation and cancer.

  2015cites this paper
• Claudin-1 overexpression in intestinal epithelial cells enhances susceptibility to adenamatous polyposis coli-mediated colon tumorigenesis

  2014cites this paper
• Gut microbial metabolism drives transformation of MSH2-deficient colon epithelial cells.

  2014cites this paper
• The gut microbiota, bacterial metabolites and colorectal cancer

  2014cites this paper
• Molecular mechanisms of oncogene-induced inflammation and inflammation-sustained oncogene activation in gastrointestinal tumors: an under-appreciated symbiotic relationship.

  2014cites this paper
• The gut microbiota in mouse models of inflammatory bowel disease

  2014cites this paper
• Bacterial genotoxin colibactin promotes colon tumour growth by inducing a senescence-associated secretory phenotype

  2014cites this paper
• New Mouse Models for Studying Dietary Prevention of Colorectal Cancer

  2014cites this paper
• Animal models of gastrointestinal and liver diseases. New mouse models for studying dietary prevention of colorectal cancer.

  2014cites this paper
• Lactobacillus salivarius Ren prevent the early colorectal carcinogenesis in 1, 2‐dimethylhydrazine‐induced rat model

  2014cites this paper
• Alterations in the microbiota drive interleukin-17C production from intestinal epithelial cells to promote tumorigenesis.

  2014cites this paper
• Producing T Cells − Inflammation and Are Controlled by IL-10 Adenomatous Polyps Are Driven by Microbe-Instigated Focal

  2013cites this paper
• Bacterial oncogenesis in the colon.

  2013cites this paper